Cargando…
Serum neurofilament light chain: a novel biomarker for early diabetic sensorimotor polyneuropathy
AIMS/HYPOTHESIS: No established blood-based biomarker exists to monitor diabetic sensorimotor polyneuropathy (DSPN) and evaluate treatment response. The neurofilament light chain (NFL), a blood biomarker of neuroaxonal damage in several neurodegenerative diseases, represents a potential biomarker fo...
Autores principales: | Maalmi, Haifa, Strom, Alexander, Petrera, Agnese, Hauck, Stefanie M., Strassburger, Klaus, Kuss, Oliver, Zaharia, Oana-Patricia, Bönhof, Gidon J., Rathmann, Wolfgang, Trenkamp, Sandra, Burkart, Volker, Szendroedi, Julia, Ziegler, Dan, Roden, Michael, Herder, Christian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9892145/ https://www.ncbi.nlm.nih.gov/pubmed/36472640 http://dx.doi.org/10.1007/s00125-022-05846-8 |
Ejemplares similares
-
Differences in the prevalence of erectile dysfunction between novel subgroups of recent-onset diabetes
por: Maalmi, Haifa, et al.
Publicado: (2021) -
Effect of obesity on the associations of 25-hydroxyvitamin D with prevalent and incident distal sensorimotor polyneuropathy: population-based KORA F4/FF4 study
por: Maalmi, Haifa, et al.
Publicado: (2022) -
Association of Long-Term Air Pollution with Prevalence and Incidence of Distal Sensorimotor Polyneuropathy: KORA F4/FF4 Study
por: Herder, Christian, et al.
Publicado: (2020) -
Deficits in systemic biomarkers of neuroinflammation and growth factors promoting nerve regeneration in patients with type 2 diabetes and polyneuropathy
por: Ziegler, Dan, et al.
Publicado: (2019) -
BOND study: a randomised double-blind, placebo-controlled trial over 12 months to assess the effects of benfotiamine on morphometric, neurophysiological and clinical measures in patients with type 2 diabetes with symptomatic polyneuropathy
por: Bönhof, Gidon J, et al.
Publicado: (2022)